We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
-10.74%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$389M
AUM Growth
-$64.4M
Cap. Flow
-$8.43M
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.99%
Holding
441
New
20
Increased
68
Reduced
75
Closed
17

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$2.58M
2
OKTA icon
Okta
OKTA
+$619K
3
SCHW
Charles Schwab
SCHW
+$514K
4
ADBE icon
Adobe
ADBE
+$512K
5
AMZN icon
Amazon
AMZN
+$477K

Top Sells

Rank Stock Value
1
DOV icon
Dover
DOV
+$371K
2
CHD icon
Church & Dwight Co
CHD
+$312K
3
BMY icon
Bristol-Myers Squibb
BMY
+$276K
4
IAU icon
iShares Gold Trust
IAU
+$265K
5
RMD icon
ResMed
RMD
+$202K

Sector Composition

Rank Sector Weight
1 Technology 23.48%
2 Healthcare 14.39%
3 Miscellaneous 14.13%
4 Consumer Staples 13.42%
5 Financials 11.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OGN icon
201
Organon & Co
OGN
$3.61B
$47K 0.01%
1,400
-17
-1% -$595
CHX
202
DELISTED
ChampionX
CHX
$46K 0.01%
2,337
NXPI icon
203
NXP Semiconductors
NXPI
$56.4B
$44K 0.01%
300
CI icon
204
Cigna
CI
$73.7B
$42K 0.01%
158
+150
+1,875% +$38.7K
IMO icon
205
Imperial Oil
IMO
$63.1B
$42K 0.01%
900
SO icon
206
Southern Company
SO
$102B
$42K 0.01%
587
-308
-34% -$22.6K
IRM icon
207
Iron Mountain
IRM
$35B
$39K 0.01%
808
-581
-42% -$30.6K
EXAS
208
DELISTED
Exact Sciences
EXAS
$37K 0.01%
950
IVV icon
209
iShares Core S&P 500 ETF
IVV
$898B
$37K 0.01%
97
ZTS icon
210
Zoetis
ZTS
$32B
$37K 0.01%
215
ACN icon
211
Accenture
ACN
$116B
$34K 0.01%
124
STT icon
212
State Street
STT
$53.1B
$34K 0.01%
550
AGG icon
213
iShares Core US Aggregate Bond ETF
AGG
$138B
$33K 0.01%
325
-5
-2% -$514
FDS icon
214
Factset
FDS
$11B
$33K 0.01%
85
-15
-15% -$5.87K
FTV icon
215
Fortive
FTV
$18B
$33K 0.01%
796
NOC icon
216
Northrop Grumman
NOC
$77.5B
$33K 0.01%
70
HSY icon
217
Hershey
HSY
$36B
$32K 0.01%
150
UTHR icon
218
United Therapeutics
UTHR
$22.1B
$32K 0.01%
135
CFG icon
219
Citizens Financial Group
CFG
$29.4B
$31K 0.01%
882
+757
+606% +$29.9K
EEM icon
220
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$30K 0.01%
747
+100
+15% +$4.2K
LMT icon
221
Lockheed Martin
LMT
$130B
$30K 0.01%
70
MS icon
222
Morgan Stanley
MS
$337B
$30K 0.01%
400
BOTZ icon
223
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.4B
$29K 0.01%
1,425
CMA
224
DELISTED
Comerica
CMA
$29K 0.01%
400
-50
-11% -$4.04K
FMAT icon
225
Fidelity MSCI Materials Index ETF
FMAT
$622M
$29K 0.01%
700

Similar funds

American Research & Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, American Research & Management Company held 441 positions worth $389M, down 14% from $454M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

American Research & Management Company's Q2 2022 filing shows 20 new, 68 increased, 75 reduced and 17 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,810 shares worth $369K. The largest sale was Dover, an estimated $371K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Miscellaneous.

  • American Research & Management Company's largest Q2 2022 buy was Vanguard Short-Term Bond ETF: 4,810 shares worth $369K.
  • American Research & Management Company added most to Freeport-McMoran in Q2 2022, an estimated $2.58M increase.
  • American Research & Management Company's biggest Q2 2022 reduction was Dover, cutting an estimated $371K.
  • American Research & Management Company fully exited Unifirst Corp in Q2 2022, selling an estimated $110K.
  • American Research & Management Company's ten largest holdings make up 32% of its $389M portfolio in Q2 2022.
  • American Research & Management Company opened 20 new positions and closed 17 in Q2 2022.
  • American Research & Management Company's portfolio value fell 14% quarter-over-quarter to $389M.

Based on American Research & Management Company's 13F filing for Q2 2022, filed 22 Jul 2022.